Taran S. Lundgren

The Immune Response to the fVIII Gene Therapy in Preclinical Models

H. Spencer, C. Doering, K. Pratt, 2020, Frontiers in Immunology.

Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway

W. H. Baldwin, S. Stowell, C. Doering, 2022, Frontiers in Immunology.

Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice

S. Stowell, H. Spencer, C. Doering, 2022, Blood Advances.

Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII

H. Spencer, C. Doering, Athena L. Russell, 2021, Molecular therapy. Methods & clinical development.